Bayer has filed a patent for a fluid injection system and fluid verification system that ensures a syringe is fully filled with fluid and does not contain air bubbles. The system uses imaging processing techniques to determine injection parameters and verify the type and properties of the fluid in the syringe. GlobalData’s report on Bayer gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Bayer, Peptide pharmacophores was a key innovation area identified from patents. Bayer's grant share as of September 2023 was 57%. Grant share is based on the ratio of number of grants to total number of patents.
Fluid injection system with fluid verification and imaging processing
A recently filed patent (Publication Number: US20230310758A1) describes a fluid injection system that utilizes image capture and computing technology to improve the accuracy and effectiveness of injection procedures. The system includes a fluid injector, a syringe, an image capture device, and at least one computing device.
In one embodiment, the computing device is equipped with a processor that obtains an image of the syringe and analyzes it to determine various characteristics of the injection procedure. These characteristics may include the flow rate, volume of fluid remaining in the syringe, and capacitance measurement of the syringe. Based on this analysis, the system can adjust the injection procedure to ensure that the fluid is delivered to a specific region of interest in the patient's body at the desired time, resulting in high-quality images during an imaging procedure.
Another embodiment of the fluid injection system focuses on monitoring the internal pressure of the syringe during the injection procedure. The system includes a syringe with a expandable portion that changes in diameter as the internal pressure increases. An image capture device captures an image of this portion, and the computing device measures its diameter. By correlating the measured diameter with known diameters at different internal pressures, the system can determine the internal pressure corresponding to the measured diameter. This information is then displayed on a connected display device. Additionally, the system can automatically adjust the syringe internal pressure based on the measured diameter, further enhancing the accuracy of the injection procedure.
The patent also describes a fluid injection system that can detect the presence of air in the syringe. The system utilizes an image capture device to capture an image of the syringe barrel, and the computing device analyzes the image to determine the position of objects within the barrel. Based on this analysis, the system can determine whether the syringe is filled with a specific type of fluid, partially filled with air, or completely filled with air. This information is then displayed on a connected display device. If air is detected, the system can disable the fluid injector to prevent an injection procedure from being conducted.
Overall, this patent presents innovative solutions for improving the accuracy and safety of fluid injection procedures. By utilizing image capture and computing technology, the system can optimize injection parameters, monitor internal pressure, and detect the presence of air, ultimately enhancing the quality of medical imaging procedures and patient care.
To know more about GlobalData’s detailed insights on Bayer, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
